
US Stocks Rally on Iran De-escalation Hopes, Lilly Bets $7.8B on Sleep Drug
U.S. stocks rallied sharply on Tuesday amid signs of potential de-escalation in the Iran conflict, with the S&P 500 gaining over 2%. Eli Lilly made a significant move by announcing the acquisition of Centessa Pharmaceuticals for up to $7.8 billion to enhance its neuroscience pipeline, focusing on sleep disorder treatments like narcolepsy. The deal includes Centessa's promising drug cleminorexton, with analysts projecting strong sales potential. Other market developments included Novo Nordisk's competitive pricing for Wegovy and mixed analyst coverage on Corning. Upcoming earnings from major companies and key economic data, such as ADP payrolls and retail sales, are anticipated to shape market direction.






















